RankingsPricing
  1. JP-listed companies
  2. EnBio Holdings,Inc
  3. Financials
  4. Cash from financing

EnBio Holdings,IncJP:6092

Market cap
¥4.8B
P/E ratio
6.7x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndCash from financing (Million JPY)YoY (%)
Mar 31, 20251,274+99.40%
Mar 31, 2024639+165.41%
Mar 31, 2023241-145.00%
Mar 31, 2022-535-157.61%
Mar 31, 2021929-122.86%
Mar 31, 2020-4,062+2540.94%
Mar 31, 2019-154-102.65%
Mar 31, 20185,813+91.38%
Mar 31, 20173,038+6.78%
Mar 31, 20162,845+86.13%
Mar 31, 20151,528

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)